LINC02887

Across TCGA pan-cancer cohorts, LINC02887 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of LINC02887’s most consistent transcriptional readouts.

The strongest signal is observed in cholangiocarcinoma (CHOL), where LINC02887 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02887 is over-expressed in tumor.

CHOL, READ, and LIHC are the cancer types where LINC02887 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02887 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CHOL	All	II,III,IV	+0.459	.004	4	view →
READ	All	All	+0.196	.036	2	view →
LIHC	All	All	+0.030	.019	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

LINC02887–CHOL

Open the CHOL breakdown →